Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $8.30. The company has a 50 day simple moving average of $0.14 and a two-hundred day simple moving average of $0.86.

Ampio Pharmaceuticals Company Profile

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Featured Stories

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.